HONG KONG · DIRECTORS' NOTICES

WuXi Biologics (Cayman) Inc.

02269 · Healthcare · Biotechnology

Score

Not ranked: no net buying on the exchange by a director in the last 180 days.

Price vs insider buying

2269.HK · HKD

● Purchase　× Sale　◇ Public disclosure　▥ 15-day cluster ·

Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.

Insider timeline

No purchase in the last 180 days; 1 insiders sold.

Tap an item for what it means.

×A sale

A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.

Blue line: this share's price, +47.2% over these six months

The closing price of each day, from 33.06 on 2026-05-11 to 48.68 on 2026-11-05. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.

Who traded

Insider	Role	Purchases	Sales	Bought	First purchase	Share price since
Li Ge	Board member	—	1	—	—	—

Director trades on the exchange

Purchases and sales on the exchange in the last 12 months, as counted in the score.

Trade date	Filed	Director	Held as	Trade	Shares	Price	Value
2026-10-13	2026-10-16	Li Ge	—	Sold	90,000,000	HK$52.31	HK$4.7B
2026-01-20	2026-01-23	Li Ge	—	Sold	150,000,000	HK$38.52	HK$5.8B

Purchases not counted · 3

Director notices of a purchase that the score leaves out, and why.

Trade date	Director	Why not counted	Shares
2022-01-11	Chen Zhisheng	Held through a trust or jointly	202,000
2021-11-09	Chen Zhisheng	Held through a trust or jointly	200,000
2021-11-04	Chen Zhisheng	Held through a trust or jointly	370,000